Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III trial of naphthoquine + azithromycin for malaria prevention
ChiCTR-IIR-17012222Phase 3Completed
- Sponsor
- Yunnan Institute of Parasitic Diseases
- Start
- Sep 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in malaria comparing Treatment group: naphthoquine + azithromycin, Active control: naphthoquine and Placebo group (3 arms). Primary endpoint: Protection rate. Started Sep 2010; status: completed.
02
Drugs
naphthoquineazithromycin
03
Conditions
malaria
Beyond the preview
Go deeper on ChiCTR-IIR-17012222.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IIR-17012222.